Smithfield Trust’s Abiomed Inc ABMD Stock Holding History

Smithfield Trust’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-38	Closed	-$10K	–	1075
2022 Q3	$10K	Hold	38	–	–	﹤0.01%	783
2022 Q2	$10K	Hold	38	–	–	﹤0.01%	821
2022 Q1	$13K	Hold	38	–	–	﹤0.01%	803
2021 Q4	$13K	Hold	38	–	–	﹤0.01%	805
2021 Q3	$12K	Hold	38	–	–	﹤0.01%	811
2021 Q2	$12K	Hold	38	–	–	﹤0.01%	798
2021 Q1	$12K	Hold	38	–	–	﹤0.01%	803
2020 Q4	$12K	Hold	38	–	–	﹤0.01%	783
2020 Q3	$10K	Buy	38 +23	+153%	+$6.63K	﹤0.01%	781
2020 Q2	$4K	Buy	+15	New	+$3.01K	﹤0.01%	900
2020 Q1	–	Sell	-25	Closed	-$4K	–	1030
2019 Q4	$4K	Hold	25	–	–	﹤0.01%	849
2019 Q3	$4K	Sell	25 -21	-46%	-$4.54K	﹤0.01%	881
2019 Q2	$12K	Hold	46	–	–	﹤0.01%	706
2019 Q1	$13K	Hold	46	–	–	﹤0.01%	650
2018 Q4	$15K	Hold	46	–	–	﹤0.01%	609
2018 Q3	$20K	Hold	46	–	–	﹤0.01%	646
2018 Q2	$19K	Buy	46 +21	+84%	+$7.61K	﹤0.01%	658
2018 Q1	$7K	Hold	25	–	–	﹤0.01%	780
2017 Q4	$5K	Buy	+25	New	+$4.67K	﹤0.01%	867

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Smithfield Trust's ABMD Position: Q4 2022 in Review

Smithfield Trust sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 38 shares — an estimated $10K sold.

Smithfield Trust first reported a position in ABMD in Q4 2017 and held it in 19 quarters. The position peaked at $20K in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Smithfield Trust reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Smithfield Trust sold 38 Abiomed Inc shares in Q4 2022, an estimated $10K.
Smithfield Trust first reported a position in Abiomed Inc in Q4 2017 and held it in 19 quarters.
Smithfield Trust's Abiomed Inc position peaked at $20K in Q3 2018.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Smithfield Trust's 13F filing for Q4 2022, filed 13 Feb 2023.